Intradermal Implantation of Bovine Collagen: Humoral Immune Responses Associated With Clinical Reactions

Ronald J. Siegle, J. Philip Mccoy, William Schade, Neil Swanson

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

A special collagen implant (Zyderm) (ZCI) is a biomaterial used for the correction of dermal contour deformities. Although infrequent, reactions believed to be of an immunologic nature have followed treatment. To investigate whether humoral immunity is associated with these reactions, we studied 40 patients for the presence of anti-ZCI antibodies using an enzyme-linked immunosorbent assay. Ten patients who had had adverse treatment reactions uniformly exhibited circulating anti-ZCI antibodies. Twenty-nine of 30 control patients, including nine who had received ZCI without adverse reaction, failed to produce the high levels of antibodies found in all clinical reactors. This difference was statistically significant. Additional investigations confirmed that the antibodies studied were directed primarily against the bovine collagen component of the ZCI. These data suggest that the humoral immune system is capable of recognizing ZCI and that the presence of antibodies to the ZCI correlates with the occurrence of adverse reactions.

Original languageEnglish (US)
Pages (from-to)183-187
Number of pages5
JournalArchives of Dermatology
Volume120
Issue number2
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Humoral Immunity
Collagen
Antibodies
Anti-Idiotypic Antibodies
Biocompatible Materials
Immune System
Enzyme-Linked Immunosorbent Assay
Skin
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Intradermal Implantation of Bovine Collagen : Humoral Immune Responses Associated With Clinical Reactions. / Siegle, Ronald J.; Mccoy, J. Philip; Schade, William; Swanson, Neil.

In: Archives of Dermatology, Vol. 120, No. 2, 1984, p. 183-187.

Research output: Contribution to journalArticle

Siegle, Ronald J. ; Mccoy, J. Philip ; Schade, William ; Swanson, Neil. / Intradermal Implantation of Bovine Collagen : Humoral Immune Responses Associated With Clinical Reactions. In: Archives of Dermatology. 1984 ; Vol. 120, No. 2. pp. 183-187.
@article{6f0358247f4042efae392d1d03f10629,
title = "Intradermal Implantation of Bovine Collagen: Humoral Immune Responses Associated With Clinical Reactions",
abstract = "A special collagen implant (Zyderm) (ZCI) is a biomaterial used for the correction of dermal contour deformities. Although infrequent, reactions believed to be of an immunologic nature have followed treatment. To investigate whether humoral immunity is associated with these reactions, we studied 40 patients for the presence of anti-ZCI antibodies using an enzyme-linked immunosorbent assay. Ten patients who had had adverse treatment reactions uniformly exhibited circulating anti-ZCI antibodies. Twenty-nine of 30 control patients, including nine who had received ZCI without adverse reaction, failed to produce the high levels of antibodies found in all clinical reactors. This difference was statistically significant. Additional investigations confirmed that the antibodies studied were directed primarily against the bovine collagen component of the ZCI. These data suggest that the humoral immune system is capable of recognizing ZCI and that the presence of antibodies to the ZCI correlates with the occurrence of adverse reactions.",
author = "Siegle, {Ronald J.} and Mccoy, {J. Philip} and William Schade and Neil Swanson",
year = "1984",
doi = "10.1001/archderm.1984.01650380043008",
language = "English (US)",
volume = "120",
pages = "183--187",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Intradermal Implantation of Bovine Collagen

T2 - Humoral Immune Responses Associated With Clinical Reactions

AU - Siegle, Ronald J.

AU - Mccoy, J. Philip

AU - Schade, William

AU - Swanson, Neil

PY - 1984

Y1 - 1984

N2 - A special collagen implant (Zyderm) (ZCI) is a biomaterial used for the correction of dermal contour deformities. Although infrequent, reactions believed to be of an immunologic nature have followed treatment. To investigate whether humoral immunity is associated with these reactions, we studied 40 patients for the presence of anti-ZCI antibodies using an enzyme-linked immunosorbent assay. Ten patients who had had adverse treatment reactions uniformly exhibited circulating anti-ZCI antibodies. Twenty-nine of 30 control patients, including nine who had received ZCI without adverse reaction, failed to produce the high levels of antibodies found in all clinical reactors. This difference was statistically significant. Additional investigations confirmed that the antibodies studied were directed primarily against the bovine collagen component of the ZCI. These data suggest that the humoral immune system is capable of recognizing ZCI and that the presence of antibodies to the ZCI correlates with the occurrence of adverse reactions.

AB - A special collagen implant (Zyderm) (ZCI) is a biomaterial used for the correction of dermal contour deformities. Although infrequent, reactions believed to be of an immunologic nature have followed treatment. To investigate whether humoral immunity is associated with these reactions, we studied 40 patients for the presence of anti-ZCI antibodies using an enzyme-linked immunosorbent assay. Ten patients who had had adverse treatment reactions uniformly exhibited circulating anti-ZCI antibodies. Twenty-nine of 30 control patients, including nine who had received ZCI without adverse reaction, failed to produce the high levels of antibodies found in all clinical reactors. This difference was statistically significant. Additional investigations confirmed that the antibodies studied were directed primarily against the bovine collagen component of the ZCI. These data suggest that the humoral immune system is capable of recognizing ZCI and that the presence of antibodies to the ZCI correlates with the occurrence of adverse reactions.

UR - http://www.scopus.com/inward/record.url?scp=0021355689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021355689&partnerID=8YFLogxK

U2 - 10.1001/archderm.1984.01650380043008

DO - 10.1001/archderm.1984.01650380043008

M3 - Article

C2 - 6696470

AN - SCOPUS:0021355689

VL - 120

SP - 183

EP - 187

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 2

ER -